There's a lot of focus on weight loss as of late; not only in the diabetic community, but in the world in general. New ads for gyms and products claiming fast weight loss come out daily, women feel pressured to lose pregnancy weight within minutes from birthing their children, thin models are being airbrushed until they are nearly unrecognizable and diets are being undertaken without people understanding how/why/if it's really going to be effective. Some of my own friends are chronically doing near-starvation diets to shed weight. People seem to be focused on getting the fat off, but unless long term habits are improved, it's not going to stay off. It's great to fight the obesity epidemic, but we can't allow ourselves to go to the other extreme. Carrying excess weight isn't a good thing, but I think we're losing focus on the importance of health versus aesthetics.
A University of Sao Paulo study of 135 individuals, half with normal weight and the other half obese, suggests there is a link between obesity and the body's inability to use insulin-insulin resistance.
For residents of Colorado and Washington state, 2014 brought a profound legal and societal change. Marijuana is now available, legally, in both of those states. While the drug is cleared for medical use elsewhere, and other jurisdictions have decriminalized it, these two states have taken the profound, extra step of full legalization.
Virtually anything from the stress of a long checkout line to the first signs of menopause can trigger hormone imbalances, which reveal themselves through mood swings, fatigue, migraines, memory problems, and a lackluster sex drive.
With the first few weeks of 2014 done, those with New Year's resolutions to exercise are probably beginning to drop out. After all, how many sub-zero jogs or shaky-legged visits to the gym can one person stand? Not many, that's for sure. But before you abandon that promise altogether, how about another reminder on the usefulness of exercise?
What role does tumor necrosis factor play in insulin resistance? Have you noticed improved insulin sensitivity when you use an anti-TNF agent such as Etanercept ? Do you recommend Etanercept for all your type 2 patients?
The Mayo Clinic Health Letter for August 2012 has published three lifestyle changes that could stave off the progression of prediabetes to full-blown type 2 diabetes. The list isn't new, but its periodic reiteration indicates that healthcare researchers and providers have settled on a simple prescription for staying diabetes-free.
The Food and Drug Administration has approved US sale of generic pioglitazone (trade name Actos) for the treatment of type 2 diabetes. Actos, originally developed and trademarked by Takeda Pharmaceuticals, works by decreasing insulin resistance in type 2 patients. The prescription drug, which belongs to the class of drugs known as thiazolidinediones (TZDs), has enjoyed great commercial success in the United States since its introduction in 1999, posting estimated sales last year of $2.7 billion.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health.
Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.